Stay updated on Adjuvant Nivo/Ipi for Melanoma Clinical Trial
Sign up to get notified when there's something new on the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page.

Latest updates to the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page
- Check2 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check9 days agoChange DetectedThe changes are minor system/version updates (Revision: v3.4.2) and the removal of an older status notice (Revision: v3.4.1); no core content or study details were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check23 days agoChange DetectedA site-wide funding notice was added and the page version updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check30 days agoChange DetectedThe page now includes a Show glossary toggle and new metadata fields: Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. It also removes the Melanoma topic and several related topics (MedlinePlus Genetics, and related items).SummaryDifference0.5%

- Check37 days agoChange DetectedMetadata updates added Melanoma and MedlinePlus Genetics related topics, and introduced a Last Update Posted (Estimated) field while removing older Last Update entries. These changes do not modify core study content, eligibility criteria, or outcome measures (To avoid being alerted by small changes, set an alert condition by clicking below.)SummaryDifference0.5%

- Check44 days agoChange DetectedThe page metadata was updated with Revision: v3.3.4 and certain tags (Melanoma, related topics: MedlinePlus Genetics, Revision: v3.3.3) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Adjuvant Nivo/Ipi for Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivo/Ipi for Melanoma Clinical Trial page.